STOPPINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.250
EU - Europa 1.677
AS - Asia 1.181
AF - Africa 4
SA - Sud America 4
OC - Oceania 3
Totale 5.119
Nazione #
US - Stati Uniti d'America 2.247
CN - Cina 1.088
IE - Irlanda 521
UA - Ucraina 296
FI - Finlandia 242
DE - Germania 165
IT - Italia 146
SE - Svezia 111
GB - Regno Unito 89
SG - Singapore 75
FR - Francia 44
BE - Belgio 21
CZ - Repubblica Ceca 17
RU - Federazione Russa 10
IN - India 7
NL - Olanda 4
PL - Polonia 4
CA - Canada 3
IR - Iran 3
JP - Giappone 3
MU - Mauritius 3
CL - Cile 2
HR - Croazia 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
RO - Romania 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
MY - Malesia 1
Totale 5.119
Città #
Chandler 535
Dublin 521
Jacksonville 360
Nanjing 317
Beijing 158
Boardman 149
Ashburn 119
Nanchang 118
Ann Arbor 98
Princeton 94
Shenyang 92
Lawrence 90
Hebei 89
Wilmington 89
Medford 74
Helsinki 70
Changsha 69
Jiaxing 66
Singapore 42
Hangzhou 41
Shanghai 38
Tianjin 38
Milan 36
Woodbridge 35
New York 32
Pavia 31
Brussels 21
Falls Church 21
Verona 21
Norwalk 17
Brno 16
Dearborn 12
Munich 11
Piscataway 11
Auburn Hills 9
Los Angeles 9
Jinan 8
Houston 7
Chicago 6
Washington 6
Kunming 5
London 5
Ningbo 5
Paris 5
Taizhou 5
Changchun 4
Padova 4
San Giuliano Milanese 4
Fairfield 3
Guangzhou 3
Hefei 3
Lanzhou 3
Naples 3
Orange 3
Redwood City 3
Rome 3
San Francisco 3
Santa Clara 3
Tappahannock 3
Tokyo 3
Bari 2
Berlin 2
Birmingham 2
Bologna 2
Borås 2
Brescia 2
Catania 2
Dallas 2
Hyderabad 2
Kamien 2
Las Vegas 2
Marsciano 2
Novokuznetsk 2
Polska 2
San Maurizio d'Opaglio 2
Seattle 2
St Petersburg 2
Toronto 2
Zagreb 2
Zanjan 2
Andover 1
Athens 1
Auckland 1
Bloomfield 1
Campo Largo 1
Des Moines 1
Focsani 1
Groningen 1
Hanover 1
Irvine 1
Kemerovo 1
Kota Kinabalu 1
Leawood 1
Melbourne 1
Moscow 1
Nairobi 1
Narbonne 1
Nürnberg 1
Oklahoma City 1
Pinehaven 1
Totale 3.709
Nome #
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 93
STRUCTURE AT 1.44 A RESOLUTION OF AN N-TERMINALLY TRUNCATED FORM OF THE RAT SERUM COMPLEMENT C3d FRAGMENT 92
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 92
Divergent biding sites in pyruvate kinase I and II from Escherichia coli. 87
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 86
Biological activity and pathological implications of misfolded proteins. 84
The molecular defect of Albumin Tagliacozzo: 313Lys--->Asn. 84
Primary structure of three peptides at the catalytic and allosteric sites of the fructose 1,6-bisphosphate-activated pyruvate kinase from Escherichia coli 84
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 78
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 77
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 76
Purification of bacteriocin AS-48 from an Enterococcus faecium strain and analysis of the gene cluster involved in its production 76
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 72
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 72
Reversed-phase high-performance liquid chromatographic separation and partial structural characterization of chloroplast glyceraldehyde-3-p dehydrogenase 70
Fluorescence detection of fibrillar proteins on silicon microstructures 70
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 70
MOLECULAR DEFECTS IN GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 68
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 68
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 68
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 68
THE PRIMARY STRUCTURE OF PISCINE (ONCORHYNCHUS MYKISS) RETINOL-BINDING PROTEIN AND A COMPARISON WITH THE THREE-DIMENSIONAL STRUCTURE OF MAMMALIAN RETINOL-BINDING PROTEIN 67
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 67
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 66
THE BOVINE PLASMA RETINOL-BINDING PROTEIN. AMINO ACID SEQUENCE, INTERACTION WITH TRANSTHYRETIN, CRYSTALLIZATION AND PRELIMINARY X-RAY DATA 66
CHLOROPLAST GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (NADP): AMINO ACID SEQUENCE OF THE SUBUNITS FROM ISOENZYME I AND STRUCTURAL RELATIONSHIP WITH ISOENZYME II 66
STRUCTURE OF THE TRIGONAL CRYSTAL FORM OF BOVINE ANNEXIN IV. 64
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 64
Proteomics of beta2-microglobulin amyloid fibrils. 64
STRUCTURAL CHARACTERIZATION OF TWO GENETIC VARIANTS OF HUMAN SERUM ALBUMIN 63
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 63
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 63
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 63
A new proalbumin variant: albumin Jaffna (-1Arg--->Leu) 62
INTERACTIONS WITH RETINOL AND RETINOIDS OF BOVINE CELLULAR RETINOL-BINDING PROTEIN 61
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 61
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 61
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 61
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 61
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 61
High-performance liquid chromatography of complex mixtures of cyanogen bromide-produced peptides from different proteins. 60
Nanobodies against beta2-microglobulin. 60
Biochimica Applicata 60
IDENTIFICATION,RETINOID BINDING, AND X-RAY ANALYSIS OF A HUMAN RETINOL-BINDING PROTEIN 58
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 58
Bacterial pyruvate kinases have a shorter N-terminal domain 58
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 58
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 58
THE PISCINE PLASMA RETINOL-BINDING PROTEIN. PURIFICATION, PARTIAL AMINO ACID SEQUENCE AND INTERACTION WITH MAMMALIAN TRANSTHYRETIN OF RAINBOW TROUT (ONCORHYNCHUS MYKISS) RETINOL-BINDING PROTEIN 57
Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity 56
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 55
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 55
Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing. 54
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 54
TWO ALLOALBUMINS WITH IDENTICAL ELECTROPHORETIC MOBILITY ARE PRODUCED BYDIFFERENTLY CHARGED AMINO ACID SUBSTITUTIONS 53
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 53
Screening of Fibrillogenesis Inhibitors of β2-microglobulin: Integrated Strategies by Mass Spectrometry, Capillary Electrophoresis and in Silico Simulations 53
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 53
Determining the energy landscape of proteins by a fast isotope exchange NMR approach. 52
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 52
structural characterization of the subunits of spinach chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP). 51
Equilibrium unfolding thermodynamics of {beta}2-microglobulin analyzed through native-state H/D exchange. 49
PROTEIN AND DNA SEQUENCE ANALYSIS OF A PRIVATE GENETIC VARIANT: ALBUMIN ORTONOVO (Glu 505--Lys) 49
Application of monoclonal anti-idiotypes in the study of AL amyloidosis: therapeutic implication 49
Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. 48
A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis 48
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 48
The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide 46
Embryonic stem and haematopoietic progenitor cells resist to Abeta oligomer toxicity and maintain the differentiation potency in culture 45
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. 45
DETECTION OF FRAGMENTS OF BETA2-MICROGLOBULIN IN AMYLOID FIBRILS 45
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile 44
Nanotechnology drives a paradigm shift on protein misfolding diseases and amyloidosis 43
Structure, folding dynamics and amyloidogenesis of Asp76Asn β2-microglobulin: roles of shear flow, hydrophobic surfaces and α crystallin. 43
Limited proteolysis of chloroplast glyceraldehyde-3-phoshate dehydrogenase (NADP) from Spinacia oleracea. 42
Screening of fibrillogenesis inhibitors of beta2-microglobulin: integrated strategie by MS, CE and docking Studies 42
Structural and functional characterization of three human immunoglobulin kappa light chains with different pathological implications. 41
Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I. 41
The solution structure of human ß2-microglobulin reveals the prodromes of its amyloid transition 41
Properties of some variants of human beta 2- microglobulin and amyloidogenesis. 38
Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-crystallin by NMR and mass spectrometry: αB-crystallin dissociates β2-microglobulin oligomers. 38
Structure, function and amyloidogenic propensity of apolipoprotein A-I. 37
Folding and fibrillogenesis: clues from beta2-microglobulin. 36
The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: A possible impact on the natural history of the disease 36
Probing the influence of citrate-capped gold nanoparticles on an amyloidogenic protein 34
Evidence that amyloidogenic light chains undergo antigen-driven selection 33
Systemic amyloidosis: lessons from beta2-microglobulin 32
Reduction of conformational mobility and aggregation in W60G β2-microglobulin: assessment by 15N NMR relaxation. 30
Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms 30
Proteomics in protein misfolding diseases. 28
Single-shot NMR measurement of protein unfolding landscapes. 24
Totale 5.212
Categoria #
all - tutte 20.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020370 0 0 0 0 8 58 11 63 4 117 101 8
2020/2021523 68 49 16 52 6 74 5 75 18 78 68 14
2021/2022421 4 4 1 5 10 29 21 26 25 18 67 211
2022/20231.499 164 134 13 120 167 131 0 87 624 12 29 18
2023/2024464 60 110 17 20 52 118 4 26 2 19 27 9
2024/2025229 26 109 35 44 15 0 0 0 0 0 0 0
Totale 5.212